Yu Peng

Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT

Jiaxin Tan, Yu You, Tubin Xu et al. · Toxicology Letters · 2013 · 53 citations

Par-4 Downregulation Confers, Oncology, Pi3k/akt Pathway-dependent Emt +8

A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma

Yu‐Zheng Ge, Hui Xin, Meng Zhu et al. · Journal of Cancer Research and Clinical Oncology · 2015 · 42 citations · Full text

Tumor-specific Microrna Signature, Urology, Genitourinary Cancer +10

MicroRNA‐218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer

Wenjing Zhu, Yiqun Shao, Yu Peng · Molecular Carcinogenesis · 2017 · 41 citations

MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma

Yu‐Zheng Ge, Hui Xin, Tian-Ze Lu et al. · Scientific Reports · 2015 · 37 citations · Full text

Asparaginyl endopeptidase promotes proliferation and invasiveness of prostate cancer cells via PI3K/AKT signaling pathway

Wenjing Zhu, Yiqun Shao, Ming Yang et al. · Gene · 2016 · 30 citations

Urology, Signal Transduction, Signaling Pathway +9